Members of the House Judiciary Committee have scheduled a hearing next week to mark up HR 3617: The Marijuana, Opportunity, Reinvestment, and Expungement (MORE) Act of 2021. The Act repeals the long-standing federal prohibition of marijuana — thereby ending the existing state/federal conflict in cannabis policies and providing state governments with greater authority to regulate marijuana-related activities, including retail sales.
Month: September 2021
NORML Supports Swift Enactment; Stresses Need for Further Federal Reforms Washington, DC: The NDAA funding…
NORML’s Deputy Director Paul Armentano said: “For millions of patients, cannabis is a legitimate therapeutic option. More and more, our laws and regulations are recognizing this fact and evolving their policies accordingly.”
In response to the public outrage regarding the suspension of American athlete Sha’Carri Richardson for testing positive for cannabis, the World Anti-Doping Agency (WADA) has announced that it will be reevaluating its policies.
NORML maintains that the NDAA is an appropriate vehicle for the SAFE banking provisions. According to the American Legion, nearly 1 in 4 veterans report consuming cannabis. Most do so because of its therapeutic effects to mitigate symptoms of a physical or mental ailment.
House Bill 241 allows law enforcement to refer a juvenile to counseling, treatment, or other appropriate intervention services in lieu of a monetary fine.
Over 54,000 Connecticut residents are currently registered to possess and and access medical cannabis
NORML Political Director Justin Strekal hosts a Facebook Live discussing the latest news and a frank discussion about marijuana policy reform at the federal level.
